Skip to main content
OpenTrials

Clinical trial condition

Peripheral Nervous System Diseases

Explore clinical trials studying Peripheral Nervous System Diseases. Study availability and eligibility vary by location and protocol.

3,196 public trials 579 recruiting studies
Refine in advanced search Browse all conditions

Peripheral Nervous System Diseases trial results

Recruiting

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT07032662

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Site Number - 1612 Tucson, Arizona, United States
  • Site Number - 1618 Carlsbad, California, United States
  • Site Number - 1619 Orange, California, United States
  • Site Number - 1607 Rancho Mirage, California, United States
View all 142 locations
View Trial Details
Recruiting

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

NCT07210515

Conditions
Autonomic Nervous System Diseases, Complex Regional Pain Syndrome Type I, Complex Regional Pain Syndromes, +9 more
Locations
  • Ambros Clinical Trial Site Phoenix, Arizona, United States
  • Ambros Clinical Trial Site Tucson, Arizona, United States
  • Ambros Clinical Trial Site Napa, California, United States
  • Ambros Clinical Trial Site Pasadena, California, United States
View all 27 locations
View Trial Details
Recruiting

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

NCT06680037

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, B-cell Mediated Autoimmune Disorders, +28 more
Locations
  • TG Therapeutics Investigational Trial Site La Jolla, California, United States
  • TG Therapeutics Investigational Trial Site Ann Arbor, Michigan, United States
  • TG Therapeutics Investigational Trial Site Omaha, Nebraska, United States
  • TG Therapeutics Investigational Trial Site New York, United States
View Trial Details
Recruiting

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

NCT02544022

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

Pan-Amyloid PET/CT in Various Amyloid-Related Disease

NCT07130565

Conditions
Alzheimer Disease, Amyloid, Amyloid Neuropathies, +21 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

NCT04561518

Conditions
ATTR Amyloidosis, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +16 more
Locations
  • Clinical Trial Site La Jolla, California, United States
  • Clinical Trial Site Los Angeles, California, United States
  • Clinical Trial Site Jacksonville, Florida, United States
  • Clinical Trial Site Iowa City, Iowa, United States
View all 40 locations
View Trial Details
Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

NCT05732831

Conditions
Adenocarcinoma, Adenoma, Carcinoma, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Grand Valley Oncology Grand Junction, Colorado, United States
  • Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 26 locations
View Trial Details
Recruiting

[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

NCT07232459

Conditions
Alzheimer Disease, Amyloid, Amyloid Neuropathies, +22 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

NCT05040373

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +15 more
Locations
  • Clinical Trial Site Iowa City, Iowa, United States
  • Clinical Trial Site Nantes, France
  • Clinical Trial Site Münster, Germany
  • Clinical Trial Site Pavia, Italy
View Trial Details

Related conditions